X

Vous n'êtes pas connecté

Rubriques :

  - ZACKS.COM - All Stories - 11/Aug 22:55

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates

Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of +69.37% and +20.84%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Articles similaires

Sorry! Image not available at this time

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 19:00

ADC Therapeutics (ADCT) delivered earnings and revenue surprises of -38.89% and +0.58%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 19:00

ADC Therapeutics (ADCT) delivered earnings and revenue surprises of -38.89% and +0.58%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 21:10

Stoke Therapeutics (STOK) delivered earnings and revenue surprises of +29.82% and +181.98%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 21:10

Stoke Therapeutics (STOK) delivered earnings and revenue surprises of +29.82% and +181.98%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 21:50

Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of -104.20% and +14.35%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 21:50

Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of -104.20% and +14.35%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates (Revised)

zacks.com - 15/Aug 20:25

Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of -44.75% and +14.35%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Travere Therapeutics (TVTX) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 06/Aug 21:15

Travere (TVTX) delivered earnings and revenue surprises of +50.00% and +17.44%, respectively, for the quarter ended June 2025. Do the numbers hold...

Sorry! Image not available at this time

Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 07/Aug 21:30

Nektar (NKTR) delivered earnings and revenue surprises of +5.75% and +3.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues...

Sorry! Image not available at this time

Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 07/Aug 21:30

Nektar (NKTR) delivered earnings and revenue surprises of +5.75% and +3.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues...

Les derniers communiqués